Malignant mixed müllerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome
- 1 March 2004
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 58 (3) , 786-796
- https://doi.org/10.1016/s0360-3016(03)01561-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Results of Primary and Adjuvant Radiotherapy in the Treatment of Mixed Müllerian Tumors of the Corpus UteriGynecologic Oncology, 1999
- The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the UterusGynecologic Oncology, 1998
- Uterine Carcinosarcomas: Incidence and Trends in Management and SurvivalGynecologic Oncology, 1997
- Parity as an Independent Prognostic Factor in Malignant Mixed Mesodermal Tumors of the EndometriumGynecologic Oncology, 1997
- Phase II Trial of Hydroxyurea, Dacarbazine (DTIC), and Etoposide (VP-16) in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- Prognostic Factors for Malignant Mixed Mullerian Tumors of the UterusInternational Journal of Gynecological Pathology, 1990
- Clinicopathologic analysis of uterine malignant mixed müllerian tumorsGynecologic Oncology, 1989
- Peritoneal cytology in malignant mixed müllerian tumors of the uterusGynecologic Oncology, 1989
- Management of malignant, mixed mesodermal tumors of the uterusGynecologic Oncology, 1989
- Carcinosarcoma of the uterus: A 40-year experience from the State of MissouriGynecologic Oncology, 1984